Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Linda M. Matusiak"'
Publikováno v:
Value in Health. 24:1279-1284
Objectives Health systems (nonfederal hospitals and clinics) are the second major source for drug expenditure in the United States. Opioids prescribed in these healthcare settings are commonly short-acting opioids that can lead to persistent opioid u
Autor:
Robert J. Hunkler, Katie J. Suda, Glen T. Schumock, JoAnn Stubbings, Michelle D. Wiest, Linda M. Matusiak, Edward C. Li, Lee C. Vermeulen
Publikováno v:
American Journal of Health-System Pharmacy. 74:1158-1173
Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2017 in nonfederal hospitals, clinics, and overall (all sectors). Methods Drug expenditure data
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37:65-70
Study objective New hepatitis C virus (HCV) antivirals have been shown to be highly effective with minimal adverse effects, but they are costly. Little is known, however, about the impact of the new HCV antivirals on expenditures in the overall U.S.
Autor:
Katie J. Suda, Lee C. Vermeulen, Linda M. Matusiak, Edward C. Li, Robert J. Hunkler, JoAnn Stubbings, Glen T. Schumock, Michelle D. Wiest
Publikováno v:
American Journal of Health-System Pharmacy. 72:717-736
Purpose An analysis of trends in U.S. pharmaceutical spending is presented, including projections for drug expenditures in nonfederal hospital and clinic settings in 2015. Methods Prescription drug expenditure data through September 2014 were obtaine
Autor:
Katie J. Suda, James M. Hoffman, Robert J. Hunkler, Edward C. Li, Linda M. Matusiak, Glen T. Schumock, Lee C. Vermeulen
Publikováno v:
American Journal of Health-System Pharmacy. 71:482-499
Purpose An analysis of trends in U.S. pharmaceutical spending is presented, including projections for drug expenditures in nonfederal hospital and clinic settings in 2014. Methods Trends in pharmaceutical expenditures and developments likely to influ
Autor:
Glen T. Schumock, Katie J. Suda, Lauri A. Hicks, Robert J. Hunkler, Rebecca M. Roberts, Linda M. Matusiak
Publikováno v:
Open Forum Infectious Diseases. 2